BFG
RMD icon

Beacon Financial Group’s ResMed RMD Stock Holding History

Beacon Financial Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,000
Closed -$217K – 182
2015
Q4 		$217K Sell
4,000
-100
-2% -$5.64K 0.05% 163
2015
Q3 		$208K Buy
+4,100
New +$221K 0.05% 160

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Beacon Financial Group's RMD Position: Q1 2016 in Review

Beacon Financial Group sold out of ResMed (RMD) in Q1 2016, closing a stake of 4,000 shares — an estimated $217K sold.

Beacon Financial Group first reported a position in RMD in Q3 2015 and held it in 2 quarters. The position peaked at $217K in Q4 2015. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2016.

  • Beacon Financial Group reported no remaining ResMed position as of Q1 2016 after selling out during the quarter.
  • Beacon Financial Group sold 4,000 ResMed shares in Q1 2016, an estimated $217K.
  • Beacon Financial Group first reported a position in ResMed in Q3 2015 and held it in 2 quarters.
  • Beacon Financial Group's ResMed position peaked at $217K in Q4 2015.
  • 374 funds tracked by Wall St. Rank held ResMed as of Q1 2016.

Based on Beacon Financial Group's 13F filing for Q1 2016, filed 1 Apr 2016.